Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) EPS (Basic) (2017 - 2020)

enVVeno Medical has reported EPS (Basic) over the past 4 years, most recently at -$2.84 for Q4 2020.

  • Quarterly results put EPS (Basic) at -$2.84 for Q4 2020, up 75.83% from a year ago — trailing twelve months through Dec 2020 was -$7.68 (up 36.58% YoY), and the annual figure for FY2025 was -$33.06, up 25.76%.
  • EPS (Basic) for Q4 2020 was -$2.84 at enVVeno Medical, down from -$1.38 in the prior quarter.
  • Over the last five years, EPS (Basic) for NVNO hit a ceiling of -$0.05 in Q4 2018 and a floor of -$11.75 in Q4 2019.
  • Median EPS (Basic) over the past 4 years was -$0.53 (2017), compared with a mean of -$1.53.
  • Biggest five-year swings in EPS (Basic): skyrocketed 90.57% in 2018 and later plummeted 23400.0% in 2019.
  • enVVeno Medical's EPS (Basic) stood at -$0.53 in 2017, then skyrocketed by 90.57% to -$0.05 in 2018, then plummeted by 23400.0% to -$11.75 in 2019, then skyrocketed by 75.83% to -$2.84 in 2020.
  • The last three reported values for EPS (Basic) were -$2.84 (Q4 2020), -$1.38 (Q3 2020), and -$1.89 (Q2 2020) per Business Quant data.